Brian J. Druker, M.D.

  • Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
  • Associate Dean, Oncology, Office of the Dean, School of Medicine
  • JELD-WEN Chair of Leukemia Research
  • Cancer Biology Graduate Program, School of Medicine
  • Program in Molecular and Cellular Biosciences, School of Medicine

Biography

Brian Druker, M.D., revolutionized the treatment of cancer through research that resulted in the first drug to target the molecular defect of a cancer while leaving healthy cells unharmed. Marketed under the name Gleevec®, his discovery turned a once-fatal cancer, chronic myeloid leukemia, into a manageable condition.

Treatment with Gleevec received FDA approval in record time, was featured on the cover of Time magazine, and established Druker as a pioneer in the field of precision medicine.  Most important, his discovery became a new proof of principle for targeted therapies, spurring the development of more than 50 similar precision therapies for other cancers.

Druker now is applying key principles of precision medicine to early detection. Earlier detection of lethal cancers represents the greatest opportunity to increase cancer survival rates. Thanks to $1 billion in philanthropic funding, Druker is developing a large-scale early detection program that builds upon the scientific strengths of OHSU’s Knight Cancer Institute.

Druker has been recognized with numerous awards, including the Sjöberg Prize from the Royal Swedish Academy of Sciences, the Warren Alpert Prize from Harvard Medical School, the Lasker-DeBakey Award for Clinical Medical Research, the Japan Prize in Healthcare and Medical Technology, the Tang Prize in Biopharmaceutical Science, and the Prince Mahidol Award for outstanding achievements in medicine and public health worldwide. He has been elected to the National Academy of Medicine, the National Academy of Sciences and the American Academy of Arts and Sciences.

Education and training

  • Degrees

    • M.D., 1981, University of California San Diego

  • Residency

    • Barnes Hospital, Washington University, St. Louis

  • Fellowship

    • Medical oncology - Dana-Farber Cancer Institute, Harvard Medical School, Boston

  • Certifications

    • American Board of Internal Medicine, 1984

Memberships and associations:

  • Institute of Medicine: National Academy of Sciences
  • American Association of Physicians
  • National Academy of Sciences
  • American Society for Clinical Investigation
  • American Society of Hematology
  • American Society of Clinical Oncology
  • American Association for Cancer Research
  • American Association for the Advancement of Science
  • American Society for Microbiology
  • Children’s Oncology Group
  • The American Society for Cell Biology

Publications

Elsevier pure profile

Publications

  • A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML

    Blood Advances
    1. Sheng F. Cai
    2. Ying Huang
    3. Jennie R. Lance
    4. Hsiaoyin Charlene Mao
    5. Andrew J. Dunbar
    6. Samantha N. McNulty
    7. Todd Druley
    8. Yan Li
    9. Maria R. Baer
    10. Wendy Stock
    11. Tibor Kovacsovics
    12. William G. Blum
    13. Gary J. Schiller
    14. Rebecca L. Olin
    15. James M. Foran
    16. Mark Litzow
    17. Tara Lin
    18. Prapti Patel
    19. Matthew C. Foster
    20. Michael Boyiadzis
    21. Robert H. Collins
    22. Jordan Chervin
    23. Abigail Shoben
    24. Jo Anne Vergilio
    25. Nyla A. Heerema
    26. Leonard Rosenberg
    27. Timothy L. Chen
    28. Ashley O. Yocum
    29. Franchesca Druggan
    30. Sonja Marcus
    31. Mona Stefanos
    32. Brian J. Druker
    33. Alice S. Mims
    34. Uma Borate
    35. Amy Burd
    36. John C. Byrd
    37. Ross L. Levine
    38. Eytan M. Stein

  • Beat-AML 2024 ELN–refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy

    Blood Advances
    1. Fieke W. Hoff
    2. William G. Blum
    3. Ying Huang
    4. Rina Li Welkie
    5. Ronan T. Swords
    6. Elie Traer
    7. Eytan M. Stein
    8. Tara L. Lin
    9. Kellie J. Archer
    10. Prapti A. Patel
    11. Robert H. Collins
    12. Maria R. Baer
    13. Vu H. Duong
    14. Martha L. Arellano
    15. Wendy Stock
    16. Olatoyosi Odenike
    17. Robert L. Redner
    18. Tibor Kovacsovics
    19. Michael W. Deininger
    20. Joshua F. Zeidner
    21. Rebecca L. Olin
    22. Catherine C. Smith
    23. James M. Foran
    24. Gary J. Schiller
    25. Emily K. Curran
    26. Kristin L. Koenig
    27. Nyla A. Heerema
    28. Timothy Chen
    29. Molly Martycz
    30. Mona Stefanos
    31. Sonja G. Marcus
    32. Leonard Rosenberg
    33. Brian J. Druker
    34. Ross L. Levine
    35. Amy Burd
    36. Ashley O. Yocum
    37. Uma Borate
    38. Alice S. Mims
    39. John C. Byrd
    40. Yazan F. Madanat

  • Comprehensive proteogenomic characterization of rare kidney tumors

    Cell Reports Medicine
    1. Ginny Xiaohe Li
    2. Lijun Chen
    3. Yi Hsiao
    4. Rahul Mannan
    5. Yuping Zhang
    6. Jie Luo
    7. Francesca Petralia
    8. Hanbyul Cho
    9. Noshad Hosseini
    10. Felipe da Veiga Leprevost
    11. Anna Calinawan
    12. Yize Li
    13. Shankara Anand
    14. Aniket Dagar
    15. Yifat Geffen
    16. Chandan Kumar-Sinha
    17. Seema Chugh
    18. Anne Le
    19. Sean Ponce
    20. Shenghao Guo
    21. Cissy Zhang
    22. Michael Schnaubelt
    23. Nataly Naser Al Deen
    24. Feng Chen
    25. Wagma Caravan
    26. Andrew Houston
    27. Alex Hopkins
    28. Chelsea J. Newton
    29. Xiaoming Wang
    30. Daniel A. Polasky
    31. Sarah Haynes
    32. Fengchao Yu
    33. Xiaojun Jing
    34. Siqi Chen
    35. Ana I. Robles
    36. Mehdi Mesri
    37. Mathangi Thiagarajan
    38. Eunkyung An
    39. Gad A. Getz
    40. W. Marston Linehan
    41. Galen Hostetter
    42. Scott D. Jewell
    43. Daniel W. Chan
    44. Pei Wang
    45. Gilbert S. Omenn
    46. Rohit Mehra
    47. Christopher J. Ricketts
    48. Li Ding
    49. Arul M. Chinnaiyan
    50. Brian J. Druker

  • Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia

    Cell Reports Medicine
    1. James C. Pino
    2. Camilo Posso
    3. Sunil K. Joshi
    4. Michael Nestor
    5. Jamie Moon
    6. Joshua R. Hansen
    7. Chelsea Hutchinson-Bunch
    8. Marina A. Gritsenko
    9. Karl K. Weitz
    10. Kevin Watanabe-Smith
    11. Nicola Long
    12. Jason E. McDermott
    13. Brian J. Druker
    14. Tao Liu
    15. Jeffrey W. Tyner
    16. Anupriya Agarwal
    17. Elie Traer
    18. Paul D. Piehowski
    19. Cristina E. Tognon
    20. Karin D. Rodland
    21. Sara J.C. Gosline

  • Pan-cancer proteogenomics characterization of tumor immunity

    Cell
    1. Francesca Petralia
    2. Weiping Ma
    3. Tomer M. Yaron
    4. Francesca Pia Caruso
    5. Nicole Tignor
    6. Joshua M. Wang
    7. Daniel Charytonowicz
    8. Jared L. Johnson
    9. Emily M. Huntsman
    10. Giacomo B. Marino
    11. Anna Calinawan
    12. John Erol Evangelista
    13. Myvizhi Esai Selvan
    14. Shrabanti Chowdhury
    15. Dmitry Rykunov
    16. Azra Krek
    17. Xiaoyu Song
    18. Berk Turhan
    19. Karen E. Christianson
    20. David A. Lewis
    21. Eden Z. Deng
    22. Daniel J.B. Clarke
    23. Jeffrey R. Whiteaker
    24. Jacob J. Kennedy
    25. Lei Zhao
    26. Rossana Lazcano Segura
    27. Harsh Batra
    28. Maria Gabriela Raso
    29. Edwin Roger Parra
    30. Rama Soundararajan
    31. Ximing Tang
    32. Yize Li
    33. Xinpei Yi
    34. Shankha Satpathy
    35. Ying Wang
    36. Maciej Wiznerowicz
    37. Tania J. González-Robles
    38. Antonio Iavarone
    39. Sara J.C. Gosline
    40. Boris Reva
    41. Ana I. Robles
    42. Alexey I. Nesvizhskii
    43. D. R. Mani
    44. Michael A. Gillette
    45. Robert J. Klein
    46. Marcin Cieslik
    47. Bing Zhang
    48. Amanda G. Paulovich
    49. Özgün Babur
    50. Brian J. Druker

  • Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors

    Leukemia
    1. Theodore P. Braun
    2. Joseph Estabrook
    3. Zachary Schonrock
    4. Brittany M. Curtiss
    5. Lucie Darmusey
    6. Jommel Macaraeg
    7. Trevor Enright
    8. Cody Coblentz
    9. Rowan Callahan
    10. William Yashar
    11. Akram Taherinasab
    12. Hisham Mohammed
    13. Daniel J. Coleman
    14. Brian J. Druker
    15. Emek Demir
    16. Theresa A. Lusardi
    17. Julia E. Maxson

  • Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy

    Blood cancer discovery
    1. Christopher A. Eide
    2. Stephen E. Kurtz
    3. Andy Kaempf
    4. Nicola Long
    5. Sunil Kumar Joshi
    6. Tamilla Nechiporuk
    7. Ariane Huang
    8. Charles A. Dibb
    9. Akosha Taylor
    10. Daniel Bottomly
    11. Shannon K. McWeeney
    12. Jessica Minnier
    13. Curtis A. Lachowiez
    14. Jennifer N. Saultz
    15. Ronan T. Swords
    16. Anupriya Agarwal
    17. Bill H. Chang
    18. Brian J. Druker
    19. Jeffrey W. Tyner

  • Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia

    Blood Advances
    1. Curtis A. Lachowiez
    2. Nicola Long
    3. Jennifer Saultz
    4. Arpita Gandhi
    5. Laura F. Newell
    6. Brandon Hayes-Lattin
    7. Richard T. Maziarz
    8. Jessica Leonard
    9. Daniel Bottomly
    10. Shannon McWeeney
    11. Jennifer Dunlap
    12. Richard Press
    13. Gabrielle Meyers
    14. Ronan Swords
    15. Rachel J. Cook
    16. Jeffrey W. Tyner
    17. Brian J. Druker
    18. Elie Traer

  • Deep learning integrates histopathology and proteogenomics at a pan-cancer level

    Cell Reports Medicine
    1. Joshua M. Wang
    2. Runyu Hong
    3. Elizabeth G. Demicco
    4. Jimin Tan
    5. Rossana Lazcano
    6. Andre L. Moreira
    7. Yize Li
    8. Anna Calinawan
    9. Narges Razavian
    10. Tobias Schraink
    11. Michael A. Gillette
    12. Gilbert S. Omenn
    13. Eunkyung An
    14. Henry Rodriguez
    15. Aristotelis Tsirigos
    16. Kelly V. Ruggles
    17. Li Ding
    18. Ana I. Robles
    19. D. R. Mani
    20. Karin D. Rodland
    21. Alexander J. Lazar
    22. Wenke Liu
    23. David Fenyö
    24. François Aguet
    25. Yo Akiyama
    26. Shankara Anand
    27. Meenakshi Anurag
    28. Özgün Babur
    29. Jasmin Bavarva
    30. Chet Birger
    31. Michael J. Birrer
    32. Lewis C. Cantley
    33. Song Cao
    34. Steven A. Carr
    35. Michele Ceccarelli
    36. Daniel W. Chan
    37. Arul M. Chinnaiyan
    38. Hanbyul Cho
    39. Shrabanti Chowdhury
    40. Marcin P. Cieslik
    41. Karl R. Clauser
    42. Antonio Colaprico
    43. Daniel Cui Zhou
    44. Felipe da Veiga Leprevost
    45. Corbin Day
    46. Saravana M. Dhanasekaran
    47. Marcin J. Domagalski
    48. Yongchao Dou
    49. Brian J. Druker
    50. Nathan Edwards

  • Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

    Molecular Cancer Research
    1. William M. Yashar
    2. Brittany M. Curtiss
    3. Daniel J. Coleman
    4. Jake VanCampen
    5. Garth Kong
    6. Jommel Macaraeg
    7. Joseph Estabrook
    8. Emek Demir
    9. Nicola Long
    10. Daniel Bottomly
    11. Shannon K. McWeeney
    12. Jeffrey W. Tyner
    13. Brian J. Druker
    14. Julia E. Maxson
    15. Theodore P. Braun

  • Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype

    Cancer
    1. Vu H. Duong
    2. Amy S. Ruppert
    3. Alice S. Mims
    4. Uma Borate
    5. Eytan M. Stein
    6. Maria R. Baer
    7. Wendy Stock
    8. Tibor Kovacsovics
    9. William Blum
    10. Martha L. Arellano
    11. Gary J. Schiller
    12. Rebecca L. Olin
    13. James M. Foran
    14. Mark R. Litzow
    15. Tara L. Lin
    16. Prapti A. Patel
    17. Matthew C. Foster
    18. Robert L. Redner
    19. Zeina Al-Mansour
    20. Christopher R. Cogle
    21. Ronan T. Swords
    22. Robert H. Collins
    23. Jo Anne Vergilio
    24. Nyla A. Heerema
    25. Leonard Rosenberg
    26. Ashley O. Yocum
    27. Sonja Marcus
    28. Timothy Chen
    29. Franchesca Druggan
    30. Mona Stefanos
    31. Theophilus J. Gana
    32. Abigail B. Shoben
    33. Brian J. Druker
    34. Amy Burd
    35. John C. Byrd
    36. Ross L. Levine
    37. Michael M. Boyiadzis

  • Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

    Cancer Cell
    1. Yize Li
    2. Tung Shing M. Lih
    3. Saravana M. Dhanasekaran
    4. Rahul Mannan
    5. Lijun Chen
    6. Marcin Cieslik
    7. Yige Wu
    8. Rita Jiu Hsien Lu
    9. David J. Clark
    10. Iga Kołodziejczak
    11. Runyu Hong
    12. Siqi Chen
    13. Yanyan Zhao
    14. Seema Chugh
    15. Wagma Caravan
    16. Nataly Naser Al Deen
    17. Noshad Hosseini
    18. Chelsea J. Newton
    19. Karsten Krug
    20. Yuanwei Xu
    21. Kyung Cho Cho
    22. Yingwei Hu
    23. Yuping Zhang
    24. Chandan Kumar-Sinha
    25. Weiping Ma
    26. Anna Calinawan
    27. Matthew A. Wyczalkowski
    28. Michael C. Wendl
    29. Yuefan Wang
    30. Shenghao Guo
    31. Cissy Zhang
    32. Anne Le
    33. Aniket Dagar
    34. Alex Hopkins
    35. Hanbyul Cho
    36. Felipe da Veiga Leprevost
    37. Xiaojun Jing
    38. Guo Ci Teo
    39. Wenke Liu
    40. Melissa A. Reimers
    41. Russell Pachynski
    42. Alexander J. Lazar
    43. Arul M. Chinnaiyan
    44. Brian A. Van Tine
    45. Bing Zhang
    46. Karin D. Rodland
    47. Gad Getz
    48. D. R. Mani
    49. Pei Wang
    50. Brian J. Druker

  • Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin

    Cancer Cell
    1. Wen Wei Liang
    2. Rita Jui Hsien Lu
    3. Reyka G. Jayasinghe
    4. Steven M. Foltz
    5. Eduard Porta-Pardo
    6. Yifat Geffen
    7. Michael C. Wendl
    8. Rossana Lazcano
    9. Iga Kolodziejczak
    10. Yizhe Song
    11. Akshay Govindan
    12. Elizabeth G. Demicco
    13. Xiang Li
    14. Yize Li
    15. Sunantha Sethuraman
    16. Samuel H. Payne
    17. David Fenyö
    18. Henry Rodriguez
    19. Maciej Wiznerowicz
    20. Hui Shen
    21. D. R. Mani
    22. Karin D. Rodland
    23. Alexander J. Lazar
    24. Ana I. Robles
    25. Li Ding
    26. François Aguet
    27. Yo Akiyama
    28. Eunkyung An
    29. Shankara Anand
    30. Meenakshi Anurag
    31. Ozgun Babur
    32. Jasmin Bavarva
    33. Chet Birger
    34. Michael Birrer
    35. Anna Calinawan
    36. Lewis C. Cantley
    37. Song Cao
    38. Steve Carr
    39. Michele Ceccarelli
    40. Daniel Chan
    41. Arul Chinnaiyan
    42. Hanbyul Cho
    43. Shrabanti Chowdhury
    44. Marcin Cieslik
    45. Karl Clauser
    46. Antonio Colaprico
    47. Daniel Cui Zhou
    48. Felipe da Veiga Leprevost
    49. Corbin Day
    50. Brian Druker

  • Kinase Mutations and Imatinib Response in Patients with Metastatic Gastrointestinal Stromal Tumor

    Journal of Clinical Oncology
    1. Michael C. Heinrich
    2. Christopher L. Corless
    3. George D. Demetri
    4. Charles D. Blanke
    5. Margaret Von Mehren
    6. Heikki Joensuu
    7. Laura S. McGreevey
    8. Chang Jie Chen
    9. Annick D. Van Den Abbeele
    10. Brian J. Druker
    11. Beate Kiese
    12. Burton Eisenberg
    13. Peter J. Roberts
    14. Samuel Singer
    15. Christopher D.M. Fletcher
    16. Sandra Silberman
    17. Sasa Dimitrijevic
    18. Jonathan A. Fletcher

  • Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia

    Haematologica
    1. Jerald P. Radich
    2. Matthew Wall
    3. Susan Branford
    4. Catarina D. Campbell
    5. Shalini Chaturvedi
    6. Daniel J. DeAngelo
    7. Michael W. Deininger
    8. Justin Guinney
    9. Andreas Hochhaus
    10. Timothy P. Hughes
    11. Hagop M. Kantarjian
    12. Richard A. Larson
    13. Sai Li
    14. Rodrigo Maegawa
    15. Kaushal Mishra
    16. Vanessa Obourn
    17. Javier Pinilla-Ibarz
    18. Das Purkayastha
    19. Islam Sadek
    20. Giuseppe Saglio
    21. Alok Shrestha
    22. Brian S. White
    23. Brian J. Druker

  • Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

    Cell
    1. Yifat Geffen
    2. Shankara Anand
    3. Yo Akiyama
    4. Tomer M. Yaron
    5. Yizhe Song
    6. Jared L. Johnson
    7. Akshay Govindan
    8. Özgün Babur
    9. Yize Li
    10. Emily Huntsman
    11. Liang Bo Wang
    12. Chet Birger
    13. David I. Heiman
    14. Qing Zhang
    15. Mendy Miller
    16. Yosef E. Maruvka
    17. Nicholas J. Haradhvala
    18. Anna Calinawan
    19. Saveliy Belkin
    20. Alexander Kerelsky
    21. Karl R. Clauser
    22. Karsten Krug
    23. Shankha Satpathy
    24. Samuel H. Payne
    25. D. R. Mani
    26. Michael A. Gillette
    27. Saravana M. Dhanasekaran
    28. Mathangi Thiagarajan
    29. Mehdi Mesri
    30. Henry Rodriguez
    31. Ana I. Robles
    32. Steven A. Carr
    33. Alexander J. Lazar
    34. François Aguet
    35. Lewis C. Cantley
    36. Li Ding
    37. Gad Getz
    38. Eunkyung An
    39. Meenakshi Anurag
    40. Jasmin Bavarva
    41. Michael J. Birrer
    42. Song Cao
    43. Michele Ceccarelli
    44. Daniel W. Chan
    45. Arul M. Chinnaiyan
    46. Hanbyul Cho
    47. Shrabanti Chowdhury
    48. Marcin P. Cieslik
    49. Antonio Colaprico
    50. Brian J. Druker

  • Pan-cancer proteogenomics connects oncogenic drivers to functional states

    Cell
    1. Yize Li
    2. Eduard Porta-Pardo
    3. Collin Tokheim
    4. Matthew H. Bailey
    5. Tomer M. Yaron
    6. Vasileios Stathias
    7. Yifat Geffen
    8. Kathleen J. Imbach
    9. Song Cao
    10. Shankara Anand
    11. Yo Akiyama
    12. Wenke Liu
    13. Matthew A. Wyczalkowski
    14. Yizhe Song
    15. Erik P. Storrs
    16. Michael C. Wendl
    17. Wubing Zhang
    18. Mustafa Sibai
    19. Victoria Ruiz-Serra
    20. Wen Wei Liang
    21. Nadezhda V. Terekhanova
    22. Fernanda Martins Rodrigues
    23. Karl R. Clauser
    24. David I. Heiman
    25. Qing Zhang
    26. Francois Aguet
    27. Anna P. Calinawan
    28. Saravana M. Dhanasekaran
    29. Chet Birger
    30. Shankha Satpathy
    31. Daniel Cui Zhou
    32. Liang Bo Wang
    33. Jessika Baral
    34. Jared L. Johnson
    35. Emily M. Huntsman
    36. Pietro Pugliese
    37. Antonio Colaprico
    38. Antonio Iavarone
    39. Milan G. Chheda
    40. Christopher J. Ricketts
    41. David Fenyö
    42. Samuel H. Payne
    43. Henry Rodriguez
    44. Ana I. Robles
    45. Michael A. Gillette
    46. Chandan Kumar-Sinha
    47. Alexander J. Lazar
    48. Lewis C. Cantley
    49. Gad Getz
    50. Brian J. Druker

  • Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases

    Clinical Cancer Research
    1. Olivia M. Lucero
    2. Ji Ann Lee
    3. Jenna Bowman
    4. Kara Johnson
    5. Gopal Sapparapu
    6. John K. Thomas
    7. Guang Fan
    8. Bill H. Chang
    9. Karina Thiel-Klare
    10. Christopher A. Eide
    11. Craig Okada
    12. Mike Palazzolo
    13. Evan Lind
    14. Yoko Kosaka
    15. Brian J. Druker
    16. Nicholas Lydon
    17. Peter M. Bowers

  • Proteogenomic insights suggest druggable pathways in endometrial carcinoma

    Cancer Cell
    1. Yongchao Dou
    2. Lizabeth Katsnelson
    3. Marina A. Gritsenko
    4. Yingwei Hu
    5. Boris Reva
    6. Runyu Hong
    7. Yi Ting Wang
    8. Iga Kolodziejczak
    9. Rita Jui Hsien Lu
    10. Chia Feng Tsai
    11. Wen Bu
    12. Wenke Liu
    13. Xiaofang Guo
    14. Eunkyung An
    15. Rebecca C. Arend
    16. Jasmin Bavarva
    17. Lijun Chen
    18. Rosalie K. Chu
    19. Andrzej Czekański
    20. Teresa Davoli
    21. Elizabeth G. Demicco
    22. Deborah DeLair
    23. Kelly Devereaux
    24. Saravana M. Dhanasekaran
    25. Peter Dottino
    26. Bailee Dover
    27. Thomas L. Fillmore
    28. McKenzie Foxall
    29. Catherine E. Hermann
    30. Tara Hiltke
    31. Galen Hostetter
    32. Marcin Jędryka
    33. Scott D. Jewell
    34. Isabelle Johnson
    35. Andrea G. Kahn
    36. Amy T. Ku
    37. Chandan Kumar-Sinha
    38. Paweł Kurzawa
    39. Alexander J. Lazar
    40. Rossana Lazcano
    41. Jonathan T. Lei
    42. Yi Li
    43. Yuxing Liao
    44. Tung Shing M. Lih
    45. Tai Tu Lin
    46. John A. Martignetti
    47. Ramya P. Masand
    48. Rafał Matkowski
    49. Wilson McKerrow
    50. Brian J. Druker

  • Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation

    American Journal of Hematology
    1. Giovanni Paolo Maria Zambrotta
    2. Franck E. Nicolini
    3. Sarit Assouline
    4. Lambert Busque
    5. Ester Pungolino
    6. Elisabetta Abruzzese
    7. Maria Cristina Miggiano
    8. Chiara Elena
    9. Alberto Alvarez-Larran
    10. Ana Triguero
    11. Alessandra Iurlo
    12. Cristina Bucelli
    13. Marco Cerrano
    14. Isabella Capodanno
    15. Francesca Lunghi
    16. Philipp le Coutre
    17. Sara Galimberti
    18. Giovanni Caocci
    19. Margherita Maffioli
    20. Fabio Stagno
    21. Susanne Saussele
    22. Rocco Piazza
    23. Brian J. Druker
    24. Carmen Fava
    25. Veronica Guglielmana
    26. Federica Colombo
    27. Laura Antolini
    28. Carlo Gambacorti-Passerini

  • Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories

    Blood Advances
    1. Uma Borate
    2. Fei Yang
    3. Richard Press
    4. Amy S. Ruppert
    5. Dan Jones
    6. Sean Caruthers
    7. Weiqiang Zhao
    8. Jo Anne Vergilio
    9. Dean C. Pavlick
    10. Luke Juckett
    11. Brianna Norris
    12. Taylor Bucy
    13. Amy Burd
    14. Eytan M. Stein
    15. Prapti Patel
    16. Maria R. Baer
    17. Wendy Stock
    18. Gary Schiller
    19. William Blum
    20. Tibor Kovacsovics
    21. Mark Litzow
    22. James Foran
    23. Nyla A. Heerema
    24. Leonard Rosenberg
    25. Sonja Marcus
    26. Ashley Yocum
    27. Mona Stefanos
    28. Brian Druker
    29. John C. Byrd
    30. Ross L. Levine
    31. Alice Mims

  • Secondary fusion proteins as a mechanism of BCR::ABL1 kinase-independent resistance in chronic myeloid leukaemia

    British Journal of Haematology
    1. Evan J. Barnes
    2. Christopher A. Eide
    3. Andy Kaempf
    4. Daniel Bottomly
    5. Kyle A. Romine
    6. Beth Wilmot
    7. Dominick Saunders
    8. Shannon K. McWeeney
    9. Cristina E. Tognon
    10. Brian J. Druker